Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study

INTRODUCTION: Lesinurad is a selective uric acid reabsorption inhibitor approved in the United States and Europe for treatment of gout in combination with a xanthine oxidase inhibitor. A maximum tolerated dose study was conducted to determine the lesinurad supratherapeutic dose, followed by a thorou...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zancong, Gillen, Michael, Tieu, Kathy, Nguyen, Mai, Harmon, Erin, Wilson, David M, Kerr, Bradley, Lee, Caroline A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096775/
https://www.ncbi.nlm.nih.gov/pubmed/27826183
http://dx.doi.org/10.2147/DDDT.S114455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096775/
https://www.ncbi.nlm.nih.gov/pubmed/27826183
http://dx.doi.org/10.2147/DDDT.S114455

Ejemplares similares